Veracyte Q1 2024 GAAP EPS $(0.02) Beats $(0.17) Estimate, Sales $96.844M Beat $93.370M Estimate
Veracyte Q1 2024 GAAP EPS $(0.02) Beats $(0.17) Estimate, Sales $96.844M Beat $93.370M Estimate
Veracyte 2024 年第一季度的 GAAP 每股收益 (0.02) 超過預期 (0.17) 美元，銷售額爲 9,684.4 萬美元超過預期 9,3370 萬美元
Veracyte (NASDAQ:VCYT) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.17) by 88.24 percent. This is a 81.82 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $96.844 million which beat the analyst consensus estimate of $93.370 million by 3.72 percent. This is a 17.50 percent increase over sales of $82.422 million the same period last year.
Veracyte（納斯達克股票代碼：VCYT）公佈的季度虧損爲每股0.02美元，比分析師普遍預期的0.17美元（0.17美元）高出88.24％。這比去年同期每股虧損0.11美元（0.11美元）增長了81.82％。該公司公佈的季度銷售額爲9,684.4萬美元，比分析師普遍預期的9,3370萬美元高出3.72％。這比去年同期的8242.2萬美元的銷售額增長了17.50％。